Time to Loss of Response following Withdrawal of Ixekizumab in Patients with Moderate-to-Severe Psoriasis

• Main Authors: Kim Papp (Author), Carle Paul (Author), C. Elise Kleyn (Author), Yu-Huei Huang (Author), Tsen-Fang Tsai (Author), Christopher Schuster (Author), Celine El Baou (Author), Agoston Toth (Author), Elisabeth Riedl (Author), Ulrich Mrowietz (Author)
• Format: Book
• Published: Medical Journals Sweden, 2022-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

In clinical practice, interruption of treatment may not result in immediate cessation of disease control, and some patients even experience sustained treatment response following treatment interruption. This post hoc analysis of UNCOVER-1 and -2 Phase 3 clinical trials characterized the time to loss...